Quarterly report · Q1
4578.TEDINET S100QQZ3
Period2023-01-01 → 2023-03-31
Filed2023-05-12
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥448.3bn | 2023-01-01 → 2023-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥1.74T | 2022-01-01 → 2022-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥380.3bn | 2022-01-01 → 2022-03-31 | Cons. | Revenue IFRS |
| Operating income | ¥76.8bn | 2023-01-01 → 2023-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥20.7bn | 2022-01-01 → 2022-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥79.2bn | 2023-01-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥173.0bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥31.0bn | 2022-01-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥61.4bn | 2023-01-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥133.9bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥23.3bn | 2022-01-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥62.7bn | 2023-01-01 → 2023-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥24.2bn | 2022-01-01 → 2022-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥3.13T | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥3.10T | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥2.89T | at 2022-03-31 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥811.5bn | at 2023-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥840.3bn | at 2022-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥2.32T | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.26T | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.10T | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.05T | at 2021-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥2.28T | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥2.23T | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥2.07T | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥477.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥471.6bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥423.4bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥410.7bn | at 2021-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥71.9bn | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥211.8bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥57.7bn | 2022-01-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥35.8bn | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥81.6bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥22.8bn | 2022-01-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥32.7bn | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥95.5bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥34.6bn | 2022-01-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥113.2 | 2023-01-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥246.8 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥42.86 | 2022-01-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥113.18 | 2023-01-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥246.78 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥42.7 | 2022-01-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 72.8% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 71.7% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 71.7% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-01-01 → 2023-03-31 | ¥42.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-01-01 → 2023-03-31 | ¥33.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥9.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-03-31 | ¥3.7bn |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-03-31 | −¥9.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-03-31 | −¥9.7bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-03-31 | −¥13.0bn |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥8.2bn |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥8.2bn |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥4m |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥2.2bn |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥104.0bn |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥104.0bn |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥13m |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥11.2bn |
| jpcrp040300-q1r_E21183-000Pharmaceuticalsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥303.2bn |
| jpcrp040300-q1r_E21183-000Pharmaceuticalsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥303.2bn |
| jpcrp040300-q1r_E21183-000Pharmaceuticalsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥72.7bn |
| —segment total | revenue | 2023-01-01 → 2023-03-31 | ¥458.0bn |
| —segment total | revenue external | 2023-01-01 → 2023-03-31 | ¥448.3bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥9.7bn |
| —segment total | segment profit | 2023-01-01 → 2023-03-31 | ¥89.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-03-31 | ¥39.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-01-01 → 2022-03-31 | ¥30.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-01-01 → 2022-03-31 | ¥8.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-03-31 | ¥4.1bn |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-03-31 | −¥8.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-03-31 | −¥8.8bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-03-31 | −¥11.7bn |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥7.7bn |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥7.7bn |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | revenue intersegment | 2022-01-01 → 2022-03-31 | ¥3m |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | segment profit | 2022-01-01 → 2022-03-31 | −¥235m |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥90.3bn |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥90.3bn |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | revenue intersegment | 2022-01-01 → 2022-03-31 | ¥3m |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | segment profit | 2022-01-01 → 2022-03-31 | ¥11.3bn |
| jpcrp040300-q1r_E21183-000Pharmaceuticalsreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥252.1bn |
| jpcrp040300-q1r_E21183-000Pharmaceuticalsreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥252.1bn |
| jpcrp040300-q1r_E21183-000Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-03-31 | ¥17.3bn |
| —segment total | revenue | 2022-01-01 → 2022-03-31 | ¥389.1bn |
| —segment total | revenue external | 2022-01-01 → 2022-03-31 | ¥380.3bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-03-31 | ¥8.8bn |
| —segment total | segment profit | 2022-01-01 → 2022-03-31 | ¥32.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 706
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 15201900 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 542446000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 5424460 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 187717 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 557835617 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 5424460 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 15201900 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 15201900 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0273 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 15201900 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 15201900 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0273 | |
| Cash and cash equivalents IFRS | Prior1YearInstant | 471634000000 | JPY |
| Cash and cash equivalents IFRS | CurrentQuarterInstant | 477137000000 | JPY |
| Trade and other receivables2 ca IFRS | Prior1YearInstant | 423426000000 | JPY |
| Trade and other receivables2 ca IFRS | CurrentQuarterInstant | 386911000000 | JPY |
| Inventories ca IFRS | Prior1YearInstant | 223507000000 | JPY |
| Inventories ca IFRS | CurrentQuarterInstant | 238903000000 | JPY |
| Income taxes receivable ca IFRS | Prior1YearInstant | 2954000000 | JPY |
| Income taxes receivable ca IFRS | CurrentQuarterInstant | 3133000000 | JPY |
| Other financial assets ca IFRS | Prior1YearInstant | 17481000000 | JPY |
| Other financial assets ca IFRS | CurrentQuarterInstant | 28738000000 | JPY |
| Other current assets ca IFRS | Prior1YearInstant | 52934000000 | JPY |
| Other current assets ca IFRS | CurrentQuarterInstant | 55671000000 | JPY |
| Current assets other than assets held for sale ca IFRS | Prior1YearInstant | 1191939000000 | JPY |
| Current assets other than assets held for sale ca IFRS | CurrentQuarterInstant | 1190496000000 | JPY |
| Assets held for sale IFRS | Prior1YearInstant | 91000000 | JPY |
| Assets held for sale IFRS | CurrentQuarterInstant | 6000000 | JPY |
| Current assets IFRS | Prior1YearInstant | 1192030000000 | JPY |
| Current assets IFRS | CurrentQuarterInstant | 1190503000000 | JPY |
| Property plant and equipment IFRS | Prior1YearInstant | 510674000000 | JPY |
| Property plant and equipment IFRS | CurrentQuarterInstant | 509789000000 | JPY |
| Goodwill IFRS | Prior1YearInstant | 335442000000 | JPY |
| Goodwill IFRS | CurrentQuarterInstant | 338178000000 | JPY |
| Intangible assets IFRS | Prior1YearInstant | 579786000000 | JPY |
| Intangible assets IFRS | CurrentQuarterInstant | 577217000000 | JPY |
| Investments accounted for using equity method IFRS | Prior1YearInstant | 241743000000 | JPY |
| Investments accounted for using equity method IFRS | CurrentQuarterInstant | 253838000000 | JPY |
| Other financial assets nca IFRS | Prior1YearInstant | 177421000000 | JPY |
| Other financial assets nca IFRS | CurrentQuarterInstant | 189338000000 | JPY |
| Deferred tax assets IFRS | Prior1YearInstant | 53383000000 | JPY |
| Deferred tax assets IFRS | CurrentQuarterInstant | 59895000000 | JPY |
| Other non current assets nca IFRS | Prior1YearInstant | 12156000000 | JPY |
| Other non current assets nca IFRS | CurrentQuarterInstant | 13280000000 | JPY |
| Non current assets IFRS | Prior1YearInstant | 1910608000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |